Discovery is the key to advancing human health. Find out how our leading researchers are pioneering new, breakthrough solutions to some of the world’s most challenging health problems.
Blood from critically ill COVID-19 patients contains antibodies that can contribute to clotting, Ishac Nazy says.
Immunologist and vaccine researcher Zhou Xing explains how he and a large team of colleagues mobilized 20 years of vaccine research to rapidly develop and test two new second-generation COVID-19 vaccine candidates.
A dopamine receptor-inhibiting drug, thioridazine, is showing promise as a new therapy for patients with acute myeloid leukemia.
McMaster logo
